Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
February 15, 2018 05:00 pm GMT

With $250 million, Peter Diamandis new startup is all about taking stem cells from placentas

Stem cells derived from a human placenta hold the key to unlocking a myriad of potentials in regenerative medicine and are the focus of X-Prize and Singularity University founder Peter Diamandis’ new endeavor. Called Celularity, the startup is a spinout from Celgene, a global biopharmaceutical company creating gene therapies. Diamandis teamed up with Dr. Robert Hariri, the founder of… Read More

Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/4Vxcfz3XwGo/

Share this article:    Share on Facebook
View Full Article

Techcrunch

TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

More About this Source Visit Techcrunch